Ko Andrew L, Ozpinar Alp, Lee Albert, Raslan Ahmed M, McCartney Shirley, Burchiel Kim J
Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon; and.
J Neurosurg. 2015 May;122(5):1048-57. doi: 10.3171/2014.12.JNS14469. Epub 2015 Feb 13.
OBJECT Trigeminal neuralgia (TN) occurs and recurs in the absence of neurovascular compression (NVC). While microvascular decompression (MVD) is the most effective treatment for TN, it is not possible when NVC is not present. Therefore, the authors sought to evaluate the safety, efficacy, and durability of internal neurolysis (IN), or "nerve combing," as a treatment for TN without NVC. METHODS This was a retrospective review of all cases of Type 1 TN involving all patients 18 years of age or older who underwent evaluation (and surgery when appropriate) at Oregon Health & Science University between July 2006 and February 2013. Chart reviews and telephone interviews were conducted to assess patient outcomes. Pain intensity was evaluated with the Barrow Neurological Institute (BNI) Pain Intensity scale, and the Brief Pain Inventory-Facial (BPI-Facial) was used to assess general and face-specific activity. Pain-free survival and durability of successful pain relief (BNI pain scores of 1 or 2) were statistically evaluated with Kaplan-Meier analysis. Prognostic factors were identified and analyzed using Cox proportional hazards regression. RESULTS A total of 177 patients with Type 1 TN were identified. A subgroup of 27 was found to have no NVC on high-resolution MRI/MR angiography or at surgery. These patients were significantly younger than patients with classic Type 1 TN. Long-term follow-up was available for 26 of 27 patients, and 23 responded to the telephone survey. The median follow-up duration was 43.4 months. Immediate postoperative results were comparable to MVD, with 85% of patients pain free and 96% of patients with successful pain relief. At 1 year and 5 years, the rate of pain-free survival was 58% and 47%, respectively. Successful pain relief at those intervals was maintained in 77% and 72% of patients. Almost all patients experienced some degree of numbness or hypesthesia (96%), but in patients with successful pain relief, this numbness did not significantly impact their quality of life. There was 1 patient with a CSF leak and 1 patient with anesthesia dolorosa. Previous treatment for TN was identified as a poor prognostic factor for successful outcome. CONCLUSIONS This is the first report of IN with meaningful outcomes data. This study demonstrated that IN is a safe, effective, and durable treatment for TN in the absence of NVC. Pain-free outcomes with IN appeared to be more durable than radiofrequency gangliolysis, and IN appears to be more effective than stereotactic radiosurgery, 2 alternatives to posterior fossa exploration in cases of TN without NVC. Given the younger age distribution of patients in this group, consideration should be given to performing IN as an initial treatment. Accrual of further outcomes data is warranted.
三叉神经痛(TN)在不存在神经血管压迫(NVC)的情况下会发生和复发。虽然微血管减压术(MVD)是治疗TN最有效的方法,但在不存在NVC时无法进行。因此,作者试图评估内部神经松解术(IN),即“神经梳理”,作为治疗无NVC的TN的安全性、有效性和持久性。方法:这是一项对2006年7月至2013年2月期间在俄勒冈健康与科学大学接受评估(并在适当情况下接受手术)的所有18岁及以上1型TN患者的回顾性研究。通过查阅病历和电话访谈来评估患者的预后。采用巴罗神经学研究所(BNI)疼痛强度量表评估疼痛强度,使用简明疼痛问卷-面部(BPI-Facial)评估一般和面部特定活动。采用Kaplan-Meier分析对无痛生存期和成功缓解疼痛(BNI疼痛评分为1或2)的持久性进行统计学评估。使用Cox比例风险回归识别和分析预后因素。结果:共识别出177例1型TN患者。在高分辨率MRI/MR血管造影或手术中发现27例患者亚组不存在NVC。这些患者明显比典型1型TN患者年轻。27例患者中有26例进行了长期随访,23例回应了电话调查。中位随访时间为43.4个月。术后即刻结果与MVD相当,85%的患者无痛,96%的患者疼痛得到成功缓解。在1年和5年时,无痛生存期分别为58%和47%。在这些时间点成功缓解疼痛的患者中,分别有77%和72%维持缓解。几乎所有患者都经历了一定程度的麻木或感觉减退(96%),但在疼痛得到成功缓解的患者中,这种麻木并未显著影响他们的生活质量。有1例患者发生脑脊液漏,1例患者出现痛性麻木。既往TN治疗被确定为成功预后的不良预测因素。结论:这是首次有意义的结果数据的IN报告。本研究表明,IN是治疗无NVC的TN的一种安全、有效且持久的方法。IN的无痛结局似乎比射频神经节溶解术更持久,且IN似乎比立体定向放射外科更有效,后两者是无NVC的TN病例中后颅窝探查的两种替代方法。鉴于该组患者年龄分布较年轻,应考虑将IN作为初始治疗方法。有必要积累更多的结局数据。